Astria Therapeutics
Fred Callori has served on our Board of Directors since January 2021. Since September 2017, Mr. Callori has served as Senior Vice President, Corporate Development at Xontogeny, LLC, life sciences accelerator. Mr. Callori is also a partner in the Perceptive Xontogeny Venture Fund. Prior to Xontogeny and Perceptive, Mr. Callori was a Partner in the Life Science and Emerging Companies practices of Choate, Hall & Stewart, LLP. Mr. Callori holds a J.D. from Boston University School of Law and a B.A. in Economics from Binghamton University.
This person is not in the org chart
This person is not in any offices
Astria Therapeutics
2 followers
With patients as their guiding stars, Astria Therapeutics’ dedicated and passionate team is devoted to bringing life-changing therapies to patients and families impacted by HAE and rare and niche allergic and immunological diseases.